TrialClinical and experimental medicine2025

Pharmacokinetics, safety, and tolerability of nacubactam (OP0595) after intravenous infusion: a randomized, double-blind, placebo-controlled phase I clinical trial in healthy Chinese male subjects.

Hui Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.